Biochemical screening revealed IC50 of 0.44 µM in conjugates, suggesting potent urease inhibition through molecular docking.
All the compounds showed better inhibitory potential than the positive control, thiourea with IC₅₀ ranging from 0.44 to 8.70 µM. However, compound 5j exhibited an excellent non-competitive urease inhibitory effect with an IC₅₀ value of 0.44 ± 0.23 µM. Apart from in vitro investigation, the molecular docking revealed a strong affinity of 5j within the active site of urease exhibiting a binding energy of -7.9 kcal/mol. Succinctly, the lead inhibitor 5j exhibited noteworthy IC₅₀ and effective binding free energy which emphasizes its strong binding potential. .
No takes yet. Share an insight, caveat, or question.
Haider et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: